Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,913.00
Bid: 1,912.00
Ask: 1,914.00
Change: -19.00 (-0.98%)
Spread: 2.00 (0.105%)
Open: 1,926.00
High: 1,926.00
Low: 1,904.00
Prev. Close: 1,932.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: Sirius plummets, Sophos climbs

Tue, 17th Sep 2019 15:02

(Sharecast News) - London's FTSE 250 was down 0.3% at 20,003.51 in afternoon trade on Tuesday, as Sirius Minerals led the index lower.

The fertiliser development company's shares tumbled as it said "poor market conditions" had forced it to cancel a $500.0m bond issue that was needed to start the next phase of construction on a fertiliser mine in Yorkshire.

Russ Mould, investment director at AJ Bell, said: "Although the share price has taken a beating on today's news, it isn't game over for Sirius and its shareholders. The miner has a few options to try and salvage the project.

"It has enough cash to give it six months' breathing space to either find a different solution for the financing or bring in a new strategic investor who could theoretically provide cash upfront in exchange for a stake in the business."

Wood Group, Premier Oil, Tullow Oil, Petrofac and Vivo Energy were all heading downward as oil prices dropped after the US tapped its Strategic Petroleum Reserves.

Up at the other end of the index, security software provider Sophos topped the risers ahead of Intermediate Capital, which climbed after appointing former Morgan Stanley veteran Alan Jones as senior managing director to build a private equity business on the other side of the Atlantic.

Shares in budget airline Wizz Air were also on the up as fears that higher oil prices could impact margins relented slightly on the back of a retreat in prices.

Finally, Hikma Pharmaceuticals climbed after launching a pre-filled syringe capability in the US, which the company said will help to improve the speed, safety and accuracy of patient care.

Market Movers

FTSE 250 (MCX) 20,003.51 -0.28%


FTSE 250 - Risers

Sophos Group (SOPH) 431.00p 7.19%
Intermediate Capital Group (ICP) 1,422.00p 3.12%
Woodford Patient Capital Trust (WPCT) 46.54p 2.86%
Games Workshop Group (GAW) 4,690.00p 2.81%
Wizz Air Holdings (WIZZ) 3,459.00p 2.58%
Telecom Plus (TEP) 1,230.00p 2.50%
Hikma Pharmaceuticals (HIK) 1,979.50p 2.19%
Softcat (SCT) 1,007.00p 2.08%
Ashmore Group (ASHM) 481.40p 1.78%
HGCapital Trust (HGT) 232.03p 1.77%

FTSE 250 - Fallers

Sirius Minerals (SXX) 4.55p -54.50%
Intu Properties (INTU) 40.16p -6.60%
Aston Martin Lagonda Global Holdings (AML) 541.20p -5.88%
Wood Group (John) (WG.) 425.20p -5.80%
Elementis (ELM) 157.90p -4.88%
Kaz Minerals (KAZ) 438.80p -4.84%
Premier Oil (PMO) 89.90p -4.52%
Tullow Oil (TLW) 231.00p -4.15%
Petrofac Ltd. (PFC) 438.80p -3.75%
Vivo Energy (VVO) 125.80p -3.23%
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.